Literature DB >> 32656861

Strategies to reduce use of antidepressants.

Tony Kendrick1.   

Abstract

Antidepressant prescribing has increased year on year since the introduction of the selective serotonin reuptake inhibitors (SSRIs) in the 1980s. More than 10% of adults in England are now taking antidepressants for depression/anxiety, with a median length of treatment of more than 2 years, but antidepressants can cause side effects and withdrawal symptoms which increase with longer use. Surveys of antidepressant users suggest 30-50% have no evidence-based indication to continue, but coming off antidepressants is often difficult due to fears of relapse, withdrawal symptoms and a lack of psychological treatments to replace maintenance treatment and prevent relapse. GPs should not prescribe antidepressants routinely for mild depressive/anxiety symptoms. Patients starting antidepressants should be advised that they are to be taken for a limited period only, and that there is a risk of withdrawal problems on stopping them. Prescribers should actively review long-term antidepressant use and suggest coming off them slowly to patients who are well. The relationship between SSRI dose and serotonin transporter receptor occupancy suggests that hyperbolic tapering regimes may be helpful for patients with troubling withdrawal symptoms who cannot stop treatment within 4-8 weeks, and tapering strips can allow carefully titrated slower dose reduction over some months. Internet and telephone support to patients wanting to reduce their antidepressants is being trialled in the REDUCE programme. More research is needed to establish the incidence of withdrawal symptoms in representative samples of patients coming off antidepressants, and large randomised controlled trials are needed to test different tapering strategies.
© 2020 The Author. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.

Entities:  

Keywords:  antidepressants; depression; health policy; prescribing; primary care

Year:  2020        PMID: 32656861     DOI: 10.1111/bcp.14475

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  4 in total

1.  Designing Flexible Longitudinal Regimens: Supporting Clinician Planning for Discontinuation of Psychiatric Drugs.

Authors:  Eunkyung Jo; Myeonghan Ryu; Georgia Kenderova; Samuel So; Bryan Shapiro; Alexandra Papoutsaki; Daniel A Epstein
Journal:  Proc SIGCHI Conf Hum Factor Comput Syst       Date:  2022-04-29

2.  Integration of Non-Targeted Metabolomics and Targeted Quantitative Analysis to Elucidate the Synergistic Antidepressant Effect of Bupleurum Chinense DC-Paeonia Lactiflora Pall Herb Pair by Regulating Purine Metabolism.

Authors:  Jiajun Chen; Tian Li; Xuemei Qin; Guanhua Du; Yuzhi Zhou
Journal:  Front Pharmacol       Date:  2022-06-30       Impact factor: 5.988

3.  Mobile phone applications to support psychotropic tapering: a scoping review protocol.

Authors:  Miriam Boland; Agnes Higgins; Gavin Doherty; Greg Sheaf; Adele Framer; Cathal Cadogan
Journal:  HRB Open Res       Date:  2022-08-19

4.  Prescription Pattern of Antidepressants and the Potential for Personalized Medicine in the Qatari Population.

Authors:  Kholoud Bastaki; Mohammed El Anbari; Suhaila Ghuloum; Puthen Veettil Jithesh
Journal:  J Pers Med       Date:  2021-05-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.